All News #Library
Biotech
Hemogenyx Pharma Reports Annual IND To FDA
14 Apr 2026 //
PHARMIWEB
Hemogenyx Pharma Updates Share Admission
22 Dec 2025 //
PHARMIWEB
Hemogenyx Pharma Updates Clinical Trial, Grants Share Awards
29 Oct 2025 //
ACCESSWIRE
Hemogenyx Pharma Cleared To Start Enrolling Pediatric Patients
06 Oct 2025 //
PHARMAWEB
Hemogenyx Pharma PLC Announces Third Patient Safety
17 Sep 2025 //
PHARMAWEB
Hemogenyx Pharma Partners with Made Scientific for Manufacturing
09 Sep 2025 //
PHARMIWEB
Hemogenyx Pharmaceuticals PLC Issues Convertible Loan Notes
01 Sep 2025 //
PHARMAWEB
Hemogenyx treats third patient with HG-CT-1 CAR-T therapy
15 Aug 2025 //
PHARMAWEB
Hemogenyx Pharma Raises £250,000, Announces Director`s Deal
29 Jul 2025 //
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Raises £451,250 in Placing
03 Jun 2025 //
ACCESSWIRE
Hemogenyx Pharma Announces Placing to Raise £451,250
08 May 2025 //
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Recruits Second Patient for Trials
17 Mar 2025 //
ACCESSWIRE
Hemogenyx Announces Ultrafast CAR-T Manufacturing
19 Dec 2024 //
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Intranasal Delivery
14 Feb 2024 //
ACCESSWIRE
Hemogenyx Announces HEMO-CAR-T Process Qualification Run Completed
08 Jan 2024 //
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T IND
10 Jul 2023 //
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-T
09 May 2023 //
ACCESSWIRE
Hemogenyx Pharma PLC Announces HEMO-CAR-T Analytical Release Tests Completed
23 Mar 2023 //
ACCESSWIRE
Hemogenyx PLC Announces HEMO-CAR-T Process Qualification Run Completed
04 Jan 2023 //
ACCESSWIRE

Market Place
Sourcing Support